Zogenix Inc Z081-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:10 AM CET
17.30quote price arrow down-0.70 (-3.89%)
52 week range
14.90 - 28.20

...

Loading . . .

KEY STATS

  • Open17.30
  • Day High17.30
  • Day Low17.30
  • Prev Close18.00
  • 52 Week High28.20
  • 52 Week High Date06/09/20
  • 52 Week Low14.90
  • 52 Week Low Date01/22/21
  • Market Cap1,180.83M
  • Shares Out55.67M
  • 10 Day Average Volume2,058.8
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-22.77

RATIOS/PROFITABILITY

  • EPS (TTM)-3.14
  • P/E (TTM)-5.51
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Zogenix Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Zogenix, Inc. is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with orphan and other CNS disorders. Its primary area of therapeutic focus is epilepsy and related seizure disorders. Its lead product candidate, ZX008, is a low-dose fenfluramine for the treatment of seizures associated with Dravet syndrome. ZX008 has received orphan drug designation in the United...
Cam Garner
Chairman
Stephen Farr Ph.D.
President
Michael Smith
Chief Financial Officer
Shawnte Mitchell
Executive Vice President
Gail Farfel Ph.D.
Executive Vice President
Address
5959 Horton St Ste 500
Emeryville, CA
94608-2120
United States